Premium
Annovis Bio Inc (ANVS)
NYSE
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company include ANVS-401, ANVS-405 and ANVS-301. Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company include ANVS-401, ANVS-405 and ANVS-301.
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.21 | 16.8 | 1.25 | 1.7083 | 1.19 | 942700 | 1.34150315 | CS |
| 4 | -0.45 | -23.5602094241 | 1.91 | 2.07 | 1.11 | 403995 | 1.43099303 | CS |
| 12 | -3.36 | -69.7095435685 | 4.82 | 5.01 | 1.11 | 488061 | 2.24841574 | CS |
| 26 | -8.64 | -85.5445544554 | 10.1 | 10.54 | 1.11 | 406298 | 3.89233553 | CS |
| 52 | -8.71 | -85.6440511308 | 10.17 | 20 | 1.11 | 781811 | 8.63902939 | CS |
| 156 | -10.58 | -87.8737541528 | 12.04 | 23.9099 | 1.11 | 331536 | 9.48382668 | CS |
| 260 | -2.37 | -61.8798955614 | 3.83 | 132 | 1.11 | 371368 | 23.67626015 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
